Torigen, Inc.

Torigen, Inc., also known as Torigen Pharmaceuticals, is a veterinary biotechnology company founded in 2012 or 2013 and based in Farmington, Connecticut.

The company specializes in developing personalized cancer immunotherapies for companion animals, including dogs, cats, and horses. Its flagship product, VetiVax, is an autologous cancer vaccine made from the pet's own tumor cells, designed to help the immune system recognize and attack cancer. Torigen offers personalized immunotherapy development, creating custom vaccines tailored to individual pets based on their tumor profiles. The company collaborates with approximately 500 veterinary clinics across the U.S. to provide innovative cancer treatment solutions. Torigen is also expanding its therapeutic focus to include new biologics for immune-mediated diseases in pets. With a commitment to making effective cancer treatment more accessible, Torigen aims to address the needs of the nearly 10 million companion animals diagnosed with cancer each year.